Uni-Bio Science Group Limited (SEHK: 690)
Health Care · Biotechnology · HK
HK$0.07
-4.11% today · -44.9% 1Y
Uni-Bio Science Group Limited (SEHK: 690) operates in the Biotechnology industry within the Health Care sector. The company is valued at $53.26M.
Over the last twelve months the share price has lost 44.9%, trading between 0.05 and 0.14.
Tweenvest scores Uni-Bio Science Group Limited across four factors: quality 76/100, value 38/100, growth 68/100, dividend 68/100. Its strongest factor is quality.
690 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $53.26M
- Revenue (TTM)
- $70.10M
- P/E
- 8.64
- EPS
- 0.01
- Dividend yield
- 4.47%
- Beta (5Y)
- -0.15
- 52-week high
- HK$0.14
- 52-week low
- HK$0.05
- Avg volume (3M)
- —
- Shares outstanding
- 5.97B
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Gossamer Bio, Inc.NasdaqGS: GOSS | $54.37M | $8.89 | -0.17% |
| Synbio Tech Inc.TPEX: 1295 | $54.02M | NT$50.10 | +2.87% |
| Boundless Bio, Inc.NasdaqGS: BOLD | $53.45M | $2.35 | -1.67% |
| Prestige BioPharma LimitedKOSE: A950210 | $53.28M | ₩5,960.00 | -2.30% |
| CG Invites Co., Ltd.KOSDAQ: A083790 | $53.19M | ₩930.00 | -3.63% |
| Prescient Therapeutics LimitedASX: PTX | $52.68M | AU$0.07 | -2.94% |
| Sirnaomics Ltd.SEHK: 2257 | $52.66M | HK$3.80 | +1.34% |
| CellSeed Inc.TSE: 7776 | $52.60M | ¥211.00 | -1.86% |
Figures last refreshed Oct 11, 2026.